Skip to main content
Scientific Reports logoLink to Scientific Reports
. 2020 Mar 2;10:3832. doi: 10.1038/s41598-020-60754-4

Behavior of 1-Deoxy-, 3-Deoxy- and N-Methyl-Ceramides in Skin Barrier Lipid Models

Andrej Kováčik 1, Petra Pullmannová 1, Ludmila Pavlíková 1, Jaroslav Maixner 2, Kateřina Vávrová 1,
PMCID: PMC7051948  PMID: 32123227

Abstract

Ceramides (Cer) are essential components of the skin permeability barrier. To probe the role of Cer polar head groups involved in the interfacial hydrogen bonding, the N-lignoceroyl sphingosine polar head was modified by removing the hydroxyls in C-1 (1-deoxy-Cer) or C-3 positions (3-deoxy-Cer) and by N-methylation of amide group (N-Me-Cer). Multilamellar skin lipid models were prepared as equimolar mixtures of Cer, lignoceric acid and cholesterol, with 5 wt% cholesteryl sulfate. In the 1-deoxy-Cer-based models, the lipid species were separated into highly ordered domains (as found by X-ray diffraction and infrared spectroscopy) resulting in similar water loss but 4–5-fold higher permeability to model substances compared to control with natural Cer. In contrast, 3-deoxy-Cer did not change lipid chain order but promoted the formation of a well-organized structure with a 10.8 nm repeat period. Yet both lipid models comprising deoxy-Cer had similar permeabilities to all markers. N-Methylation of Cer decreased lipid chain order, led to phase separation, and improved cholesterol miscibility in the lipid membranes, resulting in 3-fold increased water loss and 10-fold increased permeability to model compounds compared to control. Thus, the C-1 and C-3 hydroxyls and amide group, which are common to all Cer subclasses, considerably affect lipid miscibility and chain order, formation of periodical nanostructures, and permeability of the skin barrier lipid models.

Subject terms: Membrane biophysics, Sphingolipids

Introduction

Mammalian skin protects the body from external threats, such as chemicals and ultraviolet light, and prevents excessive water loss. The major skin permeability barrier is located in the outermost layer of the epidermis, the stratum corneum (SC)13. The SC consists of corneocytes, epidermal cells in a terminal phase of differentiation, and extracellular lipid matrix, which is a multilamellar assembly of ceramides (Cer), free fatty acids and cholesterol (Chol) in an approximately 1:1:1 molar ratio, and minor components, such as cholesteryl sulfate (CholS)13.

Cer, i.e., N-acyl sphingosines, are simple sphingolipids that have from two to four hydroxyl groups and monosubstituted amide group, which behave as hydrogen bond donors and acceptors and affect Cer interactions with proteins and other lipids. For example, 1-deoxy-Cer do not mix well with other lipids4, removal of C-3 hydroxyl in Cer prevents the formation of water-extended cooperative H-bond network of Cer5, and Cer amide group appears to be fundamental in creating the signal-transducing membrane platforms6. In the skin barrier, additional hydroxyls in Cer at C-4 (phytosphingosine Cer) or C-6 positions (6-hydroxyCer) modulate the lipid miscibility, lamellar arrangement and permeability of model SC lipid mixtures710, along with the correct acyl chain length11,12 or sphingosine chain length of Cer13,14.

Topical supplementation of skin lipids in diseases such as atopic dermatitis or ichthyoses is an established therapeutic approach. Such Cer-dominant lipids are safe, can actually prevent inflammation in atopic dermatitis and have corticoid sparing effect (for a review, see ref. 15). However, wider use of this approach is hampered by the facts that most native skin Cer are not commercially available or extremely expensive and their isolation from the skin is not possible in sufficient quantities. Thus, a detailed investigation to determine what molecular features of Cer are essential for their functions in the skin barrier can help design less expensive Cer analogues for correcting the skin barrier abnormalities.

Here we focus on the role of the polar head groups that are common to all Cer subclasses, i.e., C-1 hydroxyl, C-3 hydroxyl and amide hydrogen, in skin lipid models. N-Lignoceroyl sphingosine (CerNS in Motta nomenclature16, referred to as Cer here for brevity) was selected as the natural skin Cer for the purpose of this study because it has only the above-mentioned polar head groups (in contrast to the most abundant skin Cer based on phytosphingosine). First, we synthesized unnatural Cer, in which the hydrogen bond donors have been removed: N-lignoceroyl 1-deoxy-sphingosine (1-deoxy-Cer), N-lignoceroyl 3-deoxy-sphingosine (3-deoxy-Cer) and N-lignoceroyl N-methyl-sphingosine (N-Me-Cer; Fig. 1). Cer (either natural or modified), lignoceric acid (LIG; C24:0, the most abundant SC fatty acid17), and Chol in 1:1:1 molar ratio, with 5 weight % CholS were used to construct the lipid models. The nanostructure and thermotropic phase behavior of the lipid mixtures were probed by X-ray diffraction (XRD) and infrared spectroscopy with either unlabeled LIG or deuterated d-LIG. The barrier properties of the SC lipid models were studied using four permeability markers: water loss, flux of theophylline (TH), flux of indomethacin (IND), and electrical impedance.

Figure 1.

Figure 1

Structure of natural N-lignoceroyl sphingosine (Cer NS in Motta nomenclature16, referred to as Cer here for brevity), its unnatural analogs, i.e., 1-deoxy-Cer (the chemical modification highlighted in light blue), 3-deoxy-Cer (dark blue) and N-Me-Cer (orange), and other SC lipids used to construct the lipid barrier models.

Results

Synthesis of Cer analogs and preparation of SC lipid models

The studied Cer analogs were synthesized from the respective sphingoid bases (1-deoxy-sphingosine, or 3-deoxy-sphingosine, or N-methyl-sphingosine) and LIG using WSC and HOBt18 in the following yields: 94% for 1-deoxy-Cer, 69% for 3-deoxy-Cer and 71% for N-Me-Cer (1H and 13C NMR spectra are shown in Supporting Fig. S1). The removal of C-3 hydroxyl group and N-methylation decreased the melting temperatures of 3-deoxy-Cer (81–84 °C) and N-Me-Cer (46–48 °C), whereas the melting point of 1-deoxy-Cer (92–94 °C) was comparable to the natural Cer (89–91 °C; Supporting Fig. S2). The retention on silica gel of the prepared Cer was as follows: 1-deoxy-Cer (retention factor = 0.80) > 3-deoxy-Cer (0.75) > Cer (0.44) > N-Me-Cer (0.25). The synthesized unnatural Cer analogs along with the parent sphingosine-based Cer (all Cer with C24:0 acyl chains, the most abundant chain length in skin sphingolipids17) were used for the preparation of the SC lipid models composed of Cer/LIG/Chol in a 1:1:1 molar ratio, with an addition of 5 wt% CholS19. The samples were prepared by spraying a lipid solution on a substrate, annealing at 90 °C for 10 min, and slowly (⁓4 h) cooling to room temperature. Then the samples were maintained at 32 °C for 3 days. Whether this procedure ensures an equilibrium or near-equilibrium state of the samples is unknown. However, previous experiments showed that permeabilities12 and XRD patterns (unpublished) did not change over at least 14 days. In addition, kinetic experiments showed that Cer/fatty acid/Chol lipid mixtures either separated into domains within hours or, in case of hydrophobically matched Cer NS24/LIG, remained stable for 200 h20,21.

Lamellar and lateral organization of SC lipid models

The effects of the modified Cer on the lamellar phases and lateral packing in the lipid mixtures were investigated using XRD (Fig. 2, and Supporting Tables S2S4). To aid the interpretation of the detected phases, additional samples were prepared from pure Cer analogs and from the mixtures of Cer analogs/Chol (1:1 mol/mol) using the same preparation protocol (Supporting Fig. S3). The repeat distances, d, from two parallel samples did not differ by more than 0.01 nm, unless specified otherwise. The diffractogram of the control sample composed of physiological Cer/LIG/Chol/CholS showed a set of diffraction peaks that gave d = 5.40–5.41 nm (Fig. 2A and Supporting Table S1). The d of this short lamellar phase (SLP) is consistent with those found in analogous SC lipid models containing LIG8 or a mixture of free fatty acids with C16-C24 chain lengths9,22,23. In addition, a separated Chol phase with d(001) = 3.41 nm was found. Such separated Chol phase has also been found in the SC models12,24 and in the human SC25.

Figure 2.

Figure 2

XRD diffractograms of SC lipid models containing either Cer (panel A), or 1-deoxy-Cer (B), or 3-deoxy-Cer (C), or N-Me-Cer (D), along with LIG, Chol, and CholS. The intensity is given in arbitrary units (a. u.). Full and dashed grid lines predict the positions of SLP (panel A and D), MLP (panel C), and other structure reflections. Asterisks mark the separated Chol. The determined repeat distances are shown in the respective panels. The peaks at 0.41 nm and 0.37 nm in the wide-angle region (Q = 14–18 nm−1) indicate the orthorhombic packing of polymethylene lipid chains.

The removal of C-1 hydroxyl of Cer resulted in extensive phase separation of lipid species. Separated Chol and phases giving d = 4.68–4.71 nm and d = 5.25–5.26 nm have been found in the XRD pattern of the 1-deoxy-Cer–based model (Fig. 2B and Supporting Table S2). Separated crystalline Chol provided a set of reflections, which were attributed to Chol monohydrate triclinic lattice (space group P126). The reflections of the 5.25 nm phase were attributed to separated crystalline LIG by comparing their positions with the crystallographic data of long-chain fatty acids27. The phase with d ~4.7 nm corresponded most likely to 1-deoxy-Cer as pure 1-deoxy-Cer and 1-deoxy-Cer/Chol (1:1 mol/mol) mixture formed similar phases with d = 4.72 nm and 4.73 nm, respectively (Supporting Fig. S3). Notably, this ~4.7 nm phase is shorter than the approximate length of fully extended 1-deoxy-Cer molecule (~5.3 nm). Such structure can correspond to regularly arranged 1-deoxy-Cer molecules in V-shape conformation, similar to that proposed previously for N-(α-hydroxyoctadecanoyl)-phytosphingosine with unnatural L-configuration in α-position28.

The 3-deoxy-Cer-based lipid models showed, beside separated Chol, a set of reflections giving d = 10.80 nm (Fig. 2C and Supporting Table S3). The XRD pattern of this medium lamellar phase (MLP) contained more intense even orders (2, 4, … up to 18) and less intense odd reflections (3, 5, … up to 11) similar to MLP previously detected in the lipid mixtures with natural Cer22. The 1st order reflection was not resolved due to the technical reasons thoroughly discussed elsewhere22. The presence of LIG was essential for the formation of MLP as the mixture of 3-deoxy-Cer/Chol contained separated Chol and a crystalline structure providing the repeat distance of 5.54–5.55 nm and 3.72–3.73 nm (Supporting Fig. S3).

The N-Me-Cer/LIG/Chol/CholS sample provided sets of reflections with d = 5.35 nm (SLP) and d = 8.98–9.12 nm (Fig. 2D and Supporting Table S4). Interestingly, the reflections typical for separated Chol disappeared. Pure N-Me-Cer formed a lamellar phase with d = 5.45–5.47 nm, whereas N-Me-Cer/Chol mixture had two phases with d = 5.43 nm and 9.20 nm along with separated Chol (Supporting Fig. S3).

In addition to the phases described above, the XRD patterns contained weak additional peaks, which could not be unambiguously assigned to any structure(s). All these unassigned peaks are listed in bold in the Supporting Tables S2S4. For example, the 1-deoxy-Cer-based lipid film contained additional weak peaks at Q ~ 1.5, 3.0 and 4.6 nm−1. The assignment of any reflection requires to consider it in the context of other reflections present in the pattern and reflections observed in previous measurements, and to compare it with crystallographic data, if such data exist. Here, we feel it would be speculative to assign a solitary reflection or an incomplete set of reflections without an appropriate evidence.

The wide-angle regions of the diffractograms at the scattering vector Q = 14–18 nm−1 contain information about the polymethylene chain packing. Two peaks at the positions corresponding to distances between the scattering planes of 0.41 and 0.37 nm were found (Fig. 2), that indicate an orthorhombic chain packing (or a co-existence of hexagonal and orthorhombic chain packing)29. In human SC, orthorhombically and hexagonally-packed lipids coexist as well30. However, these reflections were poorly resolved in the pattern of the N-Me-Cer-based models and they coexisted with other reflections in the pattern of the 1-deoxy-Cer-based mixtures.

Lipid chain order at 32 °C

Next, the lipid chain order, packing, mixing and phase transitions in the SC lipid models were investigated using infrared spectroscopy7,31,32. Lipid conformation order and phase transitions can be deduced from the methylene symmetric stretching vibrations – a shift to higher wavenumbers indicates lipid disordering33. In healthy human skin, lipid chains are highly ordered as indicated by a mean wavenumber of 2848.8 cm−134. The lipid chains in the studied samples were well ordered with high proportions of all-trans conformers (wavenumbers below 2850 cm−1)35 at skin temperature (32 °C) (Fig. 3A,B). 1-Deoxy-Cer, 3-deoxy-Cer, and N-Me-Cer decreased the overall chain order compared to samples with natural Cer, as indicated by 0.9–1.3 cm−1 shifts in the methylene symmetric stretching to higher wavenumbers (Fig. 3C). Such shifts are rather large in the context of human skin lipids; for example, atopic dermatitis patients have by 0.4 cm−1 higher methylene symmetric stretching wavenumbers compared to healthy individuals34. However, all these methylene stretching wavenumbers still correspond to solid (or gel) lipid chains as liquid crystalline lipids have characteristic wavenumbers around 2852 cm−136.

Figure 3.

Figure 3

Lipid chain order in the SC lipid models containing Cer (black), 1-deoxy-Cer (light blue), 3-deoxy-Cer (dark blue), N-Me-Cer (orange), along with LIG, Chol, and CholS. Panels A and B show an example infrared spectrum and enlarged methylene symmetric stretching vibrations at 32 °C, respectively. Panel C shows the means ± SEM of the wavenumbers of the methylene symmetric vibrations; n = 2–3.

Replacement of unlabeled LIG by deuterated d-LIG enables to compare the behavior of the unlabeled methylene chains (mainly from Cer) and deuterated methylene chains (d-LIG; second graphs in Fig. 4). The methylene symmetric stretching wavenumbers suggested that in the control sample at 32 °C, both Cer (2849 cm−1) and d-LIG chains (2087 cm−1) were well ordered. The increased CH2 stretching wavenumber in this sample compared to that with unlabeled LIG was likely caused by isotopic dilution that disturbs the interchain coupling and results in such shift to higher wavenumber (while C-D bonds are less affected)37. Removal of C-3 hydroxyl did not change the wavenumbers of either 3-deoxy-Cer or d-LIG relative to the control. In the N-Me-Cer sample, the methylene symmetric stretching wavenumbers of both N-Me-Cer (2850 cm−1) and d-LIG chains (2089 cm−1) were by 1–2 cm−1 higher than those in the control Cer sample. In contrast, in 1-deoxy-Cer-based samples, the CH2 stretching wavenumbers were similar with LIG and d-LIG (2848 cm−1) indicating well ordered 1-deoxy-Cer chains and their limited mixing with (d-)LIG.

Figure 4.

Figure 4

Lipid chain order and phase transitions in the SC lipid models containing the studied Cer (black; A), 1-deoxy-Cer (light blue; B), 3-deoxy-Cer (dark blue; C), or N-Me-Cer (orange; D), along with (d)-LIG, Chol, and CholS. First graphs in each panel show the unlabeled lipid mixtures, i.e., the thermal evolution of infrared symmetric methylene stretching vibrations. Second graphs in each panel show the lipid mixtures with d-LIG, i.e., the temperature dependence of the symmetric CH2 (mainly from Cer, filled circles) and CD2 stretching vibrations (from d-LIG, open circles). The temperatures of the main phase transitions (estimated from the first derivatives of the curves) are indicated. Data are shown as means ± SEM; n = 2–3.

Phase transitions and lipid mixing

The thermal evolution of the methylene symmetric stretching vibrations can be used to determine phase transitions (as the lipids disorder upon heating, their methylene stretching modes shift to higher wavenumbers). We estimated the inflection points of the transition from the first derivatives of the curves. The lipids in Cer/LIG/Chol/CholS-containing samples first underwent a 0.2 cm−1 shift of the methylene symmetric stretching to higher wavenumbers at 37 °C (Fig. 4). This pre-transition was followed by an order-to-disorder transition at 60 °C, as indicated by a sharp shift of the wavenumber to over 2850 cm−1, which is in good agreement with previous studies8,12,38. Replacement of the unlabeled LIG by deuterated d-LIG showed that both Cer (CH2) and d-LIG (CD2) became disordered at similar temperatures (63 °C for Cer and 64 °C for d-LIG; Fig. 4A).

The lipid chains in the 1-deoxy-Cer/LIG/Chol/CholS sample (Fig. 4B) did not show any disordering up to 75 °C. Subsequently, a relatively sharp phase transition occurred at 81 °C, which is by 21 °C higher than in the control sample with natural Cer. 1-Deoxy-Cer chains and d-LIG became disordered at 83 °C and 72 °C, respectively (Fig. 4B), indicating their phase separation. In the 3-deoxy-Cer/LIG/Chol/CholS sample (Fig. 4C), the methylene symmetric stretching wavenumbers first increased by 0.5 cm−1 at 42 °C. The main order-to-disorder phase transition occurred at 68 °C. In the analogous lipid mixture with d-LIG, phase transition temperatures of 3-deoxyCer (68 °C) and d-LIG (62 °C) were rather close to those found in the control sample. In the model sample composed of N-Me-Cer/LIG/Chol/CholS, the methylene symmetric stretching wavenumbers increased slowly with increasing temperature but without any apparent pre-transition (Fig. 4D). The main phase transition was rather broad (over more than 15 °C; we estimated its inflection point at approximately 66 °C), which indicates co-existence of two or more phases, in agreement with XRD results. In the model mixture with d-LIG, the phase transitions of the CH2 chains (54 °C) and CD2 chains (70 °C) were clearly separated. However, the slight decrease of CD2 wavenumber before the main transition suggests some rearrangement of the d-LIG organization before its actual melting.

Lateral chain packing and lipid mixing

The infrared methylene rocking and scissoring bands are sensitive to the lateral packing of the lipid chains39. The splitting of the bands into doublets is indicative of an orthorhombic chain packing because the vibrations in this tight lateral packing are coupled35,40. Fig. 5 (first graphs in each panel) shows the methylene scissoring vibrations at 32 °C; the thermal evolution of the most prominent bands in this region is given in Supporting Fig. S4. Note that the relative extent of orthorhombic packing may be also affected by the relative proportions of lipids undergoing the orthorhombic-hexagonal transition. However, this comparison at 32 °C gives an estimate of the lateral packing at the temperature, at which the permeability studies were performed.

Figure 5.

Figure 5

Lateral lipid packing in the SC lipid model containing either Cer (panel A), or 1-deoxy-Cer (panel B), or 3-deoxy-Cer (panel C), or N-Me-Cer (panel D), along with (d)-LIG, Chol, and CholS. First graphs in each panel show the representative infrared spectra of the methylene scissoring vibrations of the unlabeled lipid mixtures at 32 °C. Second and third graphs in each panel show the CH2 scissoring vibration (mainly from Cer) and CD2 scissoring vibrations (d-LIG; dashed line), respectively, of the lipid mixtures with d-LIG at 32 °C. The fourth graphs in each panel show the representative infrared spectra of the methylene rocking vibrations of the unlabeled mixtures at 32 °C. A presence of a CH2/CD2 doublet in the spectrum is indicative of an orthorhombic packing. Intensity is given in arbitrary units (a. u.).

All the studied lipid models had orthorhombic doublets at approximately 1462 and 1472 cm−1, which is consistent with XRD data. However, in the N-Me-Cer lipid mixture, a central band at approximately 1468 cm−1 attributed to hexagonal packing35 dominated the scissoring region. Such coexistence of orthorhombic and hexagonal phases has also been found in human SC30. The methylene rocking bands (doublets at approximately at 719 and 729 cm−1) confirmed the presence of the orthorhombic lipid chain packing (fourth graphs in Fig. 5A–D). The ratios of the 729–719 cm−1 peak intensities that roughly estimate relative orthorhombic packing ratios (Supporting Fig. S4) were as follows: 1-deoxy-Cer > Cer = 3-deoxy-Cer > N-Me-Cer.

The orthorhombic packing disappeared with increasing temperature, either before the main transition (at 37 °C in the Cer sample) or at the onset of the main transition: at 75 °C in sample with 1-deoxy-Cer, at 65 °C with 3-deoxy-Cer, and at 51 °C with N-Me-Cer (Supporting Fig. S4, first graphs in each panel). Notably, the scissoring doublets in the 3-deoxy-Cer and 1-deoxy-Cer samples first became narrower at 42 °C and 52 °C, respectively, before dissolving into a singlet. This behavior suggests a decreased size of the orthorhombic domains and is consistent with the pre-transition at 42 °C detected in methylene symmetric stretching vibration.

The lipid chain deuteration shifts the methylene scissoring wavenumbers to approximately 1090 cm−1. Thus, the behavior of the CH2 and CD2 chains could be individually examined. In the control model lipid sample, i.e., Cer/d-LIG/Chol/CholS, CH2 and CD2 singlets were found at approximately 1468 and 1089 cm−1, respectively (second and third graphs in Fig. 5A). Thus, the scissoring doublet observed in the unlabeled sample changed into singlets upon LIG deuteration, which indicates a good mixing of d-LIG and Cer. This is because the vibrational coupling does not occur between different isotopes35. Similar scenario was observed in the 3-deoxy-Cer sample: the prevalent singlets at approximately 1090 and 1471 cm−1 suggested mostly good mixing of 3-deoxy-Cer with LIG. Notably, the CH2 singlet was rather distorted indicating that a small proportion of lipid chains was separated.

In contrast, the absence of C-1 hydroxyl in 1-deoxy-Cer resulted in a separation of rather large domains of 1-deoxy-Cer and d-LIG, as indicated by well-defined CH2 and CD2 doublets. The 1-deoxy-Cer doublet collapsed at 33 °C, whereas the d-LIG doublet persisted to 69 °C, the onset of its main transition (Supporting Fig. S4B). In the model mixture with N-Me-Cer, small orthorhombic d-LIG domains were deduced from a doublet at approximately 1093 and 1089 cm−1). This orthorhombic packing collapsed at 67 °C, with the onset of the d-LIG disordering (Supporting Fig. S4D). The carboxyl vibrations in the control Cer and 3-deoxy-Cer mixtures were located at 1718–1719 cm−1 at 32 °C, whereas they were shifted to lower wavenumbers (1703–1704 cm−1) in the 1-deoxy-Cer and N-Me-Cer samples indicating their stronger hydrogen bonding, which may be connected with the suggested LIG separation in the latter two samples (Supporting Fig. S5).

Transmembrane water loss

Next, the effects of the studied structural changes in Cer molecule on the permeabilities of the SC lipid models were probed using four markers. First, the water loss through the lipid films was investigated (Fig. 6A)19. This method is mostly used to evaluate the skin barrier condition in vivo41,42, but is also useful in in vitro studies on skin4345 and model systems43,46. The water loss through the control sample, i.e., Cer/LIG/Chol/CholS, was 1.29 ± 0.11 g/h/m2, which is consistent with the value published previously (1.40 ± 0.10 g/h/m2)9. A direct comparison of the water loss through the membrane and skin is not possible because of the differences in the instrument used, lipid amount, absence/presence of corneocytes, sweat glands, etc, but these values are mostly within the same order of magnitude34,47. Model SC mixture based on 1-deoxy-Cer had apparently (by 46%, not significant at p < 0.05) higher water loss than control. For example, in atopic dermatitis, water loss is mostly 2–3-fold higher compared to healthy individuals34,48,49. The deoxygenation of Cer in position 3 did not change the permeability of our model systems to water. In contrast, methylation of the amide nitrogen significantly (almost 3-fold) increased the water loss through the samples composed of N-Me-Cer/LIG/Chol/CholS (Fig. 6A).

Figure 6.

Figure 6

The permeabilities of the studied SC lipid models composed either of Cer (black), or 1-deoxy-Cer (blue), or 3-deoxy-Cer (dark blue), or N-Me-Cer (orange), along with LIG, Chol, and CholS. (A) Water loss; (B) permeation profile for TH; (C) the flux of TH; (D) permeation profile for IND; (E) the flux of IND; (F) electrical impedance. Data are presented as the means ± standard error of the mean (SEM), n = 5–16. The asterisks show statistically significant differences against the Cer-containing sample (p <0.05).

Permeability to TH and IND

Next, we investigated the permeabilities of the lipid models to two model permeants, TH and IND. Note that these substances were selected solely because of their different physicochemical properties without any potential clinical implications. The permeation profiles and steady-state fluxes of the model permeants are shown in Fig. 6B–E. TH is a small molecule (Mw = 180.2 g/mol) with balanced lipophilicity (logP = 0), which is likely to cross lipid membranes via free-volume diffusion50. The steady-state flux of TH for the control model sample, i.e., Cer/LIG/Chol/CholS, was 0.11 ± 0.02 µg/h/cm2. This is in good agreement with published data9. The permeability coefficient for TH through these solid lipid sample (1.22 × 10−9 cm.s−1; calculated according to Mitragotri et al.51 from the TH flux and its concentration in the donor sample52) is approximately 5 orders of magnitude lower compared to its permeability through a fluid bilayer (2.9 × 10−4 cm.s−1 has been reported for egg yolk phosphatidylcholine-based membrane53). The replacement of Cer by its analogs 1-deoxy-Cer, 3-deoxyCer and N-Me-Cer significantly increased TH flux to 0.50 ± 0.02 µg/h/cm2, 0.49 ± 0.05 µg/h/cm2, and 0.98 ± 0.16 µg/h/cm2, respectively (Fig. 6B–C). IND is a larger (Mw = 357.8 g/mol) and more lipophilic molecule (logP = 4.3) than TH, and prefers lateral diffusion along lipid layers50. The IND flux values through the samples based on Cer, 1-deoxy-Cer, 3-deoxy-Cer and N-Me-Cer were 0.06 ± 0.01 µg/h/cm2 (comparable with literature9), 0.32 ± 0.01 µg/h/cm2, 0.26 ± 0.02 µg/h/cm2 and 0.69 ± 0.05 µg/h/cm2, respectively (Fig. 6D9E). To put these numbers in context, skin permeability to various substances is 2–3.5-fold higher in atopic dermatitis patients compared to healthy volunteers (reviewed in ref. 54).

In addition, electrical impedance of the lipid films suggested that they did not have any macroscopic defects (Fig. 6F). The control and 3-deoxy-Cer membranes had electrical impedance of approximately 260–270 kΩ × cm2. The impedance of 1-deoxy-Cer membranes was approximately 40 kΩ × cm2 (which is higher than usual impedance values of in vitro human skin)55. This 6-fold decreased opposition to electrical current of 1-deoxy-Cer membranes compared to control can be explained by phase separation in that membrane. Interestingly, N-Me-Cer membranes had electrical impedance >500 kΩ × cm2. Thus, we can exclude that macroscopic defects are responsible for the high permeability of these samples to water, TH and IND. This high opposition to electrical current may be related to the improved mixing of Chol in the N-Me-Cer membranes compared to controls. Nevertheless, we cannot distinguish between the transport properties of a homogeneous structure and local defects/grain boundaries between different crystalline/ordered domains. The samples create different number of phases with periodical arrangement, and can have different crystallinity and mosaicity. Thus, we monitor the permeability of the samples as a sum of all contributing factors.

Discussion

1-deoxy-Cer

Cer lacking the primary hydroxyl at C1 occur at certain pathological conditions (e.g., hereditary sensory and autonomic neuropathy type I disease, diabetes, non-alcoholic steatohepatitis56), when the common substrate of serine palmitoyl transferase, L-serine, is replaced by L-alanine56. Such 1-deoxy-Cer cannot be metabolized to complex sphingolipids because the C-1 hydroxyl is essential for Cer binding to glucose in glucosylCer or to phosphocholine residue in sphingomyelin.

In the skin lipid models studied here, the C-1 hydroxyl in Cer with C24 acyl chain was essential for proper Cer miscibility with other SC lipids. As 1-deoxy-Cer and LIG have matching chain lengths, their altered miscibility may be related to the 1-deoxy-Cer decreased amphipathicity and/or distorted H-bonding ability. Li et al. found that C-1 hydroxyl in Cer is involved in a network of cooperative H-bonds that involves both OH groups, NH group and two molecules of water5. Although that behavior was described in solution, it seems safe to assume that the lack of C-1 hydroxyl would strongly distort the Cer interfacial H-bond network in lipid membranes as well. A similar separation of 1-deoxy-Cer-rich aggregates was found in their mixtures with sphingomyelin4. We expect that the separated domains are distributed in each layer of the film and they are larger than a scale of a lamella. These domains should contain tens of repeating units as they were detected by XRD57. Notably, chain disorder is also an important aspect as it may facilitate the formation of larger domains and less defects. For example, our control samples with native Cer have 4–20% fluid and ~1% isotropic lipids at 32 °C as found by solid state NMR58.

Despite the extensive phase separation, the water loss through 1-deoxy-Cer lipid lamellae was similar to control. Using TH and IND as model permeants, 4–5-fold increase in permeability in 1-deoxy-Cer sample over control was found, which is a relatively mild effect compared to, e.g., 79-fold increased permeability of a lipid model with short chain Cer13. This relatively good barrier of the 1-deoxyCer model lipid film may be explained by the presence of well-ordered and tightly packed lipids in the individual domains as observed by infrared spectroscopy. In addition, the 1-deoxy-Cer-rich domains will also be extremely hydrophobic that would likely hamper water loss. Thus, the permeability markers may cross the SC lipids through the phase boundaries, which will likely be a less ordered but tortuous pathway. Nevertheless, the presence of 1-deoxy-Cer in the mixture likely reduced the number/size of defects compared to a similar system without Cer (Chol/LIG/CholS) that had 20-fold lower electrical impedance and ~10-fold higher permeability to TH12.

It should be noted that XRD and infrared experiments were measured at room humidity but the lipid films in the Franz cells were exposed to a hydration gradient. Thus, the permeation experiment mimics the physiological hydration which was not possible to reach in the other experiments. However, SC is a relatively dry tissue and water is located primarily in cells59. The SC lipids do not excessively hydrate and do not swell, contrary to phospholipids (2 water molecules bind per one lipid after 24 h equilibration at 100% relative humidity60). We also performed several control XRD measurements on similar lipid systems and found neither membrane swelling nor modification of repeat distance after hydration at ~100% relative humidity for 24 h8,19, or after several cycles of hydration at 100% relative humidity (unpublished results). In addition, full hydration also did not markedly change infrared spectra of SC lipid models12. However, Pham et al. reported that the water content in the SC changed the proportions of solid and fluid lipid chains in the SC61. Thus, studies investigating the hydration effects in SC or model membranes do not correlate and this point requires further attention.

3-deoxy-Cer

A nuclear magnetic resonance study showed that C-3 hydroxyl in (dihydro)sphingosine Cer participates in their H-bond network5. The C-3 hydroxyl group is also a required substituent for a sphingomyelinase substrate62. However, other studies suggested that the C-3 hydroxyl is not necessary for sphingolipid interactions with other lipids6,63,64. For example, 3-O-methylation of Cer did not markedly alter its ability to displace Chol from interactions with sphingomyelin6.

In our model SC lipid systems, 3-deoxy-Cer mixed with LIG and Chol and formed well-organized MLP. The formation of MLP was recently observed in lipid systems consisting of 6-hydroxysphingosine-Cer9, sphingosine-Cer22, and their mixture10. We assume that the principles of the organization of MLP are similar to phase with asymmetric bilayers described for phospholipids6568 and to oriented fatty acid bilayers with well-defined asymmetric distribution of lipids57. MLP contains most likely an asymmetric unit arranged so that it provides the repeat distance over 10 nm22. However, the detail molecular arrangement of MLP is unknown. In contrast to 3-deoxy-Cer, a change of C-3 stereochemistry in Cer (from D-erythro-lignoceroyl sphingosine to its L-threo-isomer) did not affect the lamellar periodicity in the SC lipid models but diminished the Cer mixing with fatty acids and reduced the water permeability barrier of such lipid systems23. Thus, the removal of C-3 hydroxyl in Cer was apparently less detrimental for its mixing with fatty acids and the ability to create a water barrier than incorrect stereochemistry at this position.

The 4-fold increased permeability of the 3-deoxy-Cer-based systems relative to control is consistent with the barrier properties of another MLP-forming SC lipid model9. A conceivable explanation could be that MLP arrangement potentiates the permeation along the lipid lamellae. In contrast to the apparent resistance of both deoxy-Cer lipid assemblies to water loss, further hydroxylation of Cer, either in the sphingosine9 or acyl chain (Kováčik et al., unpublished data), increased water loss in similar model systems up to 2-fold compared to sphingosine Cer control.

N-Me-Cer

The rigid planar amide group of Cer was found to be oriented perpendicular toward the axes of the two hydrocarbon chains69. This amide group appears to be fundamental for the sterol displacing ability of Cer in creating signal-transducing membrane platforms6,70. Cer N-methylation lowered its melting point by more than 40 °C, indicating strongly disturbed attractive forces between N-Me-Cer molecules compared to Cer. In the model SC lipid systems, Cer N-methylation resulted in less ordered and less tightly packed lipid chains and improved mixing with Chol (compared to Cer). Interestingly, although a significant portion of LIG molecules separated from the mixture, as indicated by FTIR results, some LIG was apparently required for dissolving Chol in the lipid system (as the binary mixture of N-Me-Cer/Chol did not fully mix). Whether the driving force for this behavior was the absence of hydrogen or the presence of more lipophilic and bulkier methyl at the amide nitrogen is unknown.

The lipids in this N-Me-Cer sample created SLP and a phase with a repeat period of 9.11 nm, which was likely rich in N-Me-Cer and Chol. SLP also contained some N-Me-Cer as Chol does not mix well with LIG. Raudenkolb et al. found a structure with a repeat distance of 7.4 nm in hydrated N-(α-hydroxyoctadecanoyl)-phytosphingosine with unnatural L-configuration in α-position. They proposed a repeat unit of two V-shaped Cer ordered alternatingly28. This principle of alternating V-shaped lipids could also be consistent with the 9.11 nm phase found here (note that our N-Me-Cer has by 6 C longer acyl chain, and the angle of the V-shape conformation could be wider resulting in a larger repeat distance compared to Raudenkolb et al.28).

Consequently, the lipid model with N-Me-Cer had approximately 10-fold higher permeabilities to TH and IND and 3-fold higher water loss compared to the model with physiological Cer. This barrier impairment, which is 2–3-fold greater compared to the effects of either deoxy-Cer, may be related to the less ordered, loosely packed lipids separated into two distinct phases (but not to macroscopic defects in the lipid film as indicated by the high electrical impedance value). A question remains how Chol fully mixed with other lipids affected the permeability of such lipid assemblies. We have previously described that a 0.4:1:1 molar ratio of Chol/Cer/fatty acids appears sufficient for skin lipids to limit water loss and prevent the entry of environmental substances and that excessive Chol phase separates and rather disturbs the barrier55.

Conclusions

We have previously reported that the both acyl12 and sphingosine chains shortening13, saturation of trans-double bond71, hydroxylations in C-48,72 or C-6 position9,10 have different effects on the phase behavior and permeabilities of model skin lipid mixtures. Here we focused on the essential molecular features common to all Cer subclasses, hydroxyls at C-1 and C-3 and amide bond. These Cer polar head group modifications had an immense impact on the studied properties of the SC model lipid mixtures. The hydroxyl group in C-1 position was necessary for proper lipid mixing as the resulting 1-deoxy-Cer-based systems were fragmented into several crystalline domains. This behavior most likely underlined the moderately worsened barrier function of 1-deoxy-Cer-based SC lipid barrier models compared to those with physiological Cer. In contrast, the 3-deoxy-Cer mixed well with other lipids and, at the conditions used here, formed MLP phase with 10.8 nm periodicity. Thus, the position of hydroxyl groups in the Cer polar head is decisive for their miscibility and lamellar phase arrangement. However, the lipid systems with 3-deoxy-Cer had similar permeabilities to those with 1-deoxy-Cer highlighting the complex relationships between the structure of a lipid assembly and permeability. Methylation of the Cer nitrogen improved Cer miscibility with Chol, disordered lipid chains, and strongly increased the permeability of the systems to all studied markers compared to the control with physiological Cer. In conclusion, hydroxyl in position 1 and monosubstituted amide bond in Cer should be maintained in rational designing of lipid analogs for barrier repair therapy of skin diseases, whereas the allylic hydroxyl in position 3 can possibly be removed/replaced.

Materials and Methods

Chemicals

1-Deoxy-sphingosine (synthetic, over 99% stereochemically pure, i.e., (2 S,3 R,4E)), 3-deoxy-sphingosine (synthetic, over 99% stereochemically pure, i.e., (2 R,4E)), N-methyl-sphingosine (synthetic, over 99% stereochemically pure, i.e., (2 S,3 R,4E)) and Cer (CerNS; synthetic, over 99% stereochemically pure, i.e., (2 S,3 R,4E)) were purchased from Avanti Polar Lipids (Alabaster, USA). Deuterated lignoceric acid (d-LIG) was obtained from C/D/N isotopes (Pointe-Claire, Canada). All other chemicals and solvents were from Sigma-Aldrich (Schnelldorf, Germany). Water was deionized, distilled, and filtered through a Millipore Q purification system.

Synthesis of Cer analogs

See Supporting Information.

Preparation of lipid models

The skin barrier models were prepared as equimolar mixtures of Cer or its unnatural analogs, Chol, and LIG with the addition of 5 wt% of CholS9,46. First, the lipids were dissolved in 2:1 hexane/96% EtOH (or 96% EtOH for CholS) with sonication and mixed to yield the desired composition. The lipid solutions were evaporated under a stream of nitrogen, dried under vacuum, and then redissolved in 2:1 hexane/96% ethanol (v/v) at 4.5 mg/mL. These lipid solutions (3 × 100 µL per cm2) were slowly sprayed on Nuclepore polycarbonate filters with 15 nm pores (Whatman, Kent, UK) or on 22 mm × 22 mm supporting glass cover slides under a stream of nitrogen using a Linomat V (Camag, Muttenz, Switzerland) equipped with additional y-axis movement. This fast drying suppressed artefactual lipid unmixing during solvent evaporation. The supporting filters did not significantly contribute to membrane barrier properties8. The lipid films were heated to 90 °C, a temperature that is above the main lipid phase transitions in our samples, equilibrated for 10 min, and then slowly (~3 h) cooled to room temperature. All samples were equilibrated at 32 °C for at least 3 days before the experiments.

X-ray diffraction (XRD)

The XRD data on the lipid films on glass cover slides were collected at ambient room temperature and humidity with an X’Pert PRO θ-θ powder diffractometer (PANalytica B.V., Almelo, Netherlands) with parafocusing Bragg-Brentano geometry using CuKα radiation (λ = 1.5418 Å, U = 40 kV, I = 30 mA) in modified sample holders over the angular range of 0.6–30° (2θ). Data were scanned with an ultrafast linear (1D) position-sensitive X’Celerator detector with a step size of 0.0167° (2θ) and a counting time of 20.32 s step−1. The raw scattered intensities without normalization are shown as a function of the scattering vector Q [nm−1]. The data were evaluated using the software package X’Pert Data Viewer (PANalytical B.V., Almelo, Netherlands) as described previously9,23.

Infrared spectroscopy

Fourier-transform infrared spectra of the model SC lipid mixtures were collected on a Nicolet FTIR 6700 spectrometer (Thermo Scientific, Waltham, MA, USA) using a single-reflection MIRacle attenuated total reflectance ZnSe crystal (PIKE technologies, Madison, WI, USA). A clamping mechanism with constant pressure was used. The spectra were generated by co-addition of 256 scans collected at 2 cm−1 resolution. The temperature dependence of infrared spectra was studied over the range 28–100 °C with 2 °C steps using a temperature control module (PIKE technologies, Madison, WI, USA). The data were analyzed using Bruker OPUS software.

Permeation experiments

The permeability of the model SC lipid films was evaluated using Franz diffusion cells with an available diffusion area of 0.5 cm2 and an acceptor volume of 6.5 ± 0.1 mL. The acceptor compartment of the cell was filled with phosphate-buffered saline (PBS) at pH 7.4 with 50 mg/L gentamicin and stirred at 32 °C8. After a 24-h equilibration, we checked the samples for macroscopic defects using electrical impedance11,73. The electrical impedance was recorded using an LCR 4080 meter (Conrad Electronic, Hirschau, Germany) operated in parallel mode with an alternating frequency of 120 Hz. This setup yields the best sensitivity to small impedance changes. To record the membrane impedance, the donor compartment of the Franz diffusion cell was filled with 0.5 mL of PBS, and the tips of the stainless-steel probes were carefully immersed in PBS in the donor and acceptor compartments of the diffusion cell. Next, the membranes were equilibrated overnight and water loss [g/h/m2] through the lipid films was measured using Tewameter® TM 300 probe and Multi Probe Adapter Cutometer® MPA 580 (CK electronic GmbH, Kӧln, Germany)23. The environmental conditions were comparable during all measurements: ambient air temperature of 26–29 °C and relative air humidity of 40–46%. Next, 100 µL of the donor sample – either 5% TH or 2% IND suspensions in 60% propylene glycol – were applied to the lipid film. 60% propylene glycol does not extract lipids from the SC model membranes19 or change SC lipid chain order74. This setup ensured sink conditions for the selected drugs. Samples of the acceptor phase (300 µL) were withdrawn every 2 h over 8 h and were replaced with the same volume of PBS. During this period, a steady-state situation was reached. The acceptor phase samples were analyzed for TH and IND by HPLC using validated methods8.

Data analysis

The cumulative amounts of TH and IND were calculated from the concentration measured by HPLC and diffusion cell volume, and were corrected for the acceptor phase replacement. The cumulative amounts were plotted against time and the steady-state flux of TH (or IND) was calculated as a slope of the linear regression function obtained by the fitting the linear region of the plot in Excel. Data are presented as the means ± SEM, and the number of replicates is given in the pertinent figure. One-way analysis of variance (ANOVA) with Dunnett’s post hoc test method was used for statistical analysis and p < 0.05 was considered significant.

Supplementary information

Supplementary info. (10.6MB, docx)

Acknowledgements

This work was supported by The Czech Science Foundation (19–09135 J) and the project EFSA-CDN (No. CZ.02.1.01/0.0/0.0/16_019/0000841) co-funded by ERDF. We thank Assoc. Prof. Dr. Jiří Kuneš, Ph.D. (NMR) and Mrs. Iva Vencovská (infrared spectroscopy) for technical assistance.

Author contributions

K.V., A.K., P.P. conceived and designed the experiment. A.K., P.P., L.P., J.M. performed the experiments and analyzed data. A.K. drafted the manuscript, all listed authors reviewed the manuscript and K.V. edited the final manuscript.

Competing interests

The authors declare no competing interests.

Footnotes

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

is available for this paper at 10.1038/s41598-020-60754-4.

References

  • 1.Elias PM. Epidermal lipids, membranes, and keratinization. Int. J. Dermatol. 1981;20(1):1–19. doi: 10.1111/j.1365-4362.1981.tb05278.x. [DOI] [PubMed] [Google Scholar]
  • 2.Breiden B, Sandhoff K. The role of sphingolipid metabolism in cutaneous permeability barrier formation. Biochim. Biophys. Acta. 2014;1841(3):441–52. doi: 10.1016/j.bbalip.2013.08.010. [DOI] [PubMed] [Google Scholar]
  • 3.Rabionet M, Gorgas K, Sandhoff R. Ceramide synthesis in the epidermis. Biochim. Biophys. Acta. 2014;1841(3):422–34. doi: 10.1016/j.bbalip.2013.08.011. [DOI] [PubMed] [Google Scholar]
  • 4.Jimenez-Rojo N, et al. Biophysical properties of novel 1-deoxy-(dihydro)ceramides occurring in mammalian cells. Biophys. J. 2014;107(12):2850–2859. doi: 10.1016/j.bpj.2014.10.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Li L, Tang X, Taylor KG, DuPre DB, Yappert MC. Conformational characterization of ceramides by nuclear magnetic resonance spectroscopy. Biophys. J. 2002;82(4):2067–80. doi: 10.1016/S0006-3495(02)75554-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Maula T, et al. Effects of sphingosine 2N- and 3O-methylation on palmitoyl ceramide properties in bilayer membranes. Biophys. J. 2011;101(12):2948–56. doi: 10.1016/j.bpj.2011.11.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Rerek ME, et al. Phytosphingosine and sphingosine ceramide headgroup hydrogen bonding: Structural insights through thermotropic hydrogen/deuterium exchange. J. Phys. Chem. B. 2001;105(38):9355–9362. doi: 10.1021/jp0118367. [DOI] [Google Scholar]
  • 8.Skolova B, Kovacik A, Tesar O, Opalka L, Vavrova K. Phytosphingosine, sphingosine and dihydrosphingosine ceramides in model skin lipid membranes: permeability and biophysics. BBA - Biomembranes. 2017;1859(5):824–834. doi: 10.1016/j.bbamem.2017.01.019. [DOI] [PubMed] [Google Scholar]
  • 9.Kovacik A, Silarova M, Pullmannova P, Maixner J, Vavrova K. Effects of 6-Hydroxyceramides on the Thermotropic Phase Behavior and Permeability of Model Skin Lipid Membranes. Langmuir. 2017;33(11):2890–2899. doi: 10.1021/acs.langmuir.7b00184. [DOI] [PubMed] [Google Scholar]
  • 10.Kovacik A, et al. Probing the role of ceramide hydroxylation in skin barrier lipid models by (2)H solid-state NMR spectroscopy and X-ray powder diffraction. Biochim. Biophys. Acta. 2018;1860(5):1162–1170. doi: 10.1016/j.bbamem.2018.02.003. [DOI] [PubMed] [Google Scholar]
  • 11.Janusova B, et al. Effect of ceramide acyl chain length on skin permeability and thermotropic phase behavior of model stratum corneum lipid membranes. BBA - Biomembranes. 2011;1811(3):129–37. doi: 10.1016/j.bbalip.2010.12.003. [DOI] [PubMed] [Google Scholar]
  • 12.Skolova B, et al. Ceramides in the skin lipid membranes: length matters. Langmuir. 2013;29(50):15624–33. doi: 10.1021/la4037474. [DOI] [PubMed] [Google Scholar]
  • 13.Skolova B, Janusova B, Vavrova K. Ceramides with a pentadecasphingosine chain and short acyls have strong permeabilization effects on skin and model lipid membranes. BBA - Biomembranes. 2016;1858(2):220–32. doi: 10.1016/j.bbamem.2015.11.019. [DOI] [PubMed] [Google Scholar]
  • 14.Novotny J, Janusova B, Novotny M, Hrabalek A, Vavrova K. Short-chain ceramides decrease skin barrier properties. Skin Pharmacol. Physiol. 2009;22(1):22–30. doi: 10.1159/000183923. [DOI] [PubMed] [Google Scholar]
  • 15.Vávrová K. Emerging small-molecule compounds for treatment of atopic dermatitis: a review. Expert Opin Ther Pats. 2016;26(1):21–34. doi: 10.1517/13543776.2016.1101451. [DOI] [PubMed] [Google Scholar]
  • 16.Motta S, et al. Ceramide composition of the psoriatic scale. Biochim. Biophys. Acta. 1993;1182(2):147–51. doi: 10.1016/0925-4439(93)90135-N. [DOI] [PubMed] [Google Scholar]
  • 17.Wertz PW. Lipids and barrier function of the skin. Acta Derm. Venereol. Suppl. (Stockh.) 2000;208:7–11. doi: 10.1080/000155500750042790. [DOI] [PubMed] [Google Scholar]
  • 18.Kovacik A, Opalka L, Silarova M, Roh J, Vavrova K. Synthesis of 6-hydroxyceramide using ruthenium-catalyzed hydrosilylation-protodesilylation. Unexpected formation of a long periodicity lamellar phase in skin lipid membranes. RSC Adv. 2016;6(77):73343–73350. doi: 10.1039/C6RA16565F. [DOI] [Google Scholar]
  • 19.Pullmannova P, et al. Permeability and microstructure of model stratum corneum lipid membranes containing ceramides with long (C16) and very long (C24) acyl chains. Biophys. Chem. 2017;224:20–31. doi: 10.1016/j.bpc.2017.03.004. [DOI] [PubMed] [Google Scholar]
  • 20.Mendelsohn R, et al. Kinetic evidence suggests spinodal phase separation in stratum corneum models by IR spectroscopy. J. Phys. Chem. B. 2014;118(16):4378–87. doi: 10.1021/jp501003c. [DOI] [PubMed] [Google Scholar]
  • 21.Mendelsohn R, Rabie E, Walters RM, Flach CR. Fatty Acid Chain Length Dependence of Phase Separation Kinetics in Stratum Corneum Models by IR Spectroscopy. J. Phys. Chem. B. 2015;119(30):9740–50. doi: 10.1021/acs.jpcb.5b03045. [DOI] [PubMed] [Google Scholar]
  • 22.Pullmannova P, et al. Long and very long lamellar phases in model stratum corneum lipid membranes. J. Lipid Res. 2019;60(5):963–971. doi: 10.1194/jlr.M090977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Kovacik A, Pullmannova P, Maixner J, Vavrova K. Effects of Ceramide and Dihydroceramide Stereochemistry at C-3 on the Phase Behavior and Permeability of Skin Lipid Membranes. Langmuir. 2018;34(1):521–529. doi: 10.1021/acs.langmuir.7b03448. [DOI] [PubMed] [Google Scholar]
  • 24.de Jager MW, et al. The phase behaviour of skin lipid mixtures based on synthetic ceramides. Chem. Phys. Lipids. 2003;124(2):123–34.. doi: 10.1016/S0009-3084(03)00050-1. [DOI] [PubMed] [Google Scholar]
  • 25.Bouwstra JA, Gooris GS, Salomonsdevries MA, Vanderspek JA, Bras W. Structure of Human Stratum-Corneum as a Function of Temperature and Hydration - a Wide-Angle X-Ray-Diffraction Study. Int. J. Pharm. 1992;84(3):205–216. doi: 10.1016/0378-5173(92)90158-X. [DOI] [Google Scholar]
  • 26.Craven BM. Pseudosymmetry in Cholesterol Monohydrate. Acta Crystallogr. Sect. B: Struct. Sci. 1979;35(May):1123–1128. doi: 10.1107/S0567740879005719. [DOI] [Google Scholar]
  • 27.Abrahamsson S, Vonsydow E. Variation of Unit-Cell Dimensions of a Crystal Form of Long Normal Chain Carboxylic Acids. Acta Crystallogr. 1954;7(8-9):591–592. doi: 10.1107/S0365110X54001910. [DOI] [Google Scholar]
  • 28.Raudenkolb S, Wartewig S, Neubert RH. Polymorphism of ceramide 3. Part 2: a vibrational spectroscopic and X-ray powder diffraction investigation of N-octadecanoyl phytosphingosine and the analogous specifically deuterated d(35) derivative. Chem. Phys. Lipids. 2003;124(2):89–101. doi: 10.1016/S0009-3084(03)00045-8. [DOI] [PubMed] [Google Scholar]
  • 29.Bouwstra JA, Ponec M. The skin barrier in healthy and diseased state. Biochim. Biophys. Acta. 2006;1758(12):2080–95. doi: 10.1016/j.bbamem.2006.06.021. [DOI] [PubMed] [Google Scholar]
  • 30.Boncheva M, Damien F, Normand V. Molecular organization of the lipid matrix in intact Stratum corneum using ATR-FTIR spectroscopy. Biochim. Biophys. Acta. 2008;1778(5):1344–1355. doi: 10.1016/j.bbamem.2008.01.022. [DOI] [PubMed] [Google Scholar]
  • 31.Moore DJ, Rerek ME, Mendelsohn R. Lipid domains and orthorhombic phases in model stratum corneum: evidence from Fourier transform infrared spectroscopy studies. Biochem. Biophys. Res. Commun. 1997;231(3):797–801. doi: 10.1006/bbrc.1997.6189. [DOI] [PubMed] [Google Scholar]
  • 32.Chen H, Mendelsohn R, Rerek ME, Moore DJ. Fourier transform infrared spectroscopy and differential scanning calorimetry studies of fatty acid homogeneous ceramide 2. Biochim. Biophys. Acta. 2000;1468(1-2):293–303. doi: 10.1016/S0005-2736(00)00271-6. [DOI] [PubMed] [Google Scholar]
  • 33.Mantsch HH, Mcelhaney RN. Phospholipid Phase-Transitions in Model and Biological-Membranes as Studied by Infrared-Spectroscopy. Chem. Phys. Lipids. 1991;57(2–3):213–226. doi: 10.1016/0009-3084(91)90077-O. [DOI] [PubMed] [Google Scholar]
  • 34.Janssens M, et al. Increase in short-chain ceramides correlates with an altered lipid organization and decreased barrier function in atopic eczema patients. J. Lipid Res. 2012;53(12):2755–66. doi: 10.1194/jlr.P030338. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Mendelsohn R, Moore DJ. Vibrational spectroscopic studies of lipid domains in biomembranes and model systems. Chem. Phys. Lipids. 1998;96(1-2):141–57. doi: 10.1016/S0009-3084(98)00085-1. [DOI] [PubMed] [Google Scholar]
  • 36.Mantsch HH, Madec C, Lewis RN, McElhaney RN. Thermotropic phase behavior of model membranes composed of phosphatidylcholines containing iso-branched fatty acids. 2. Infrared and phosphorus-31 NMR spectroscopic studies. Biochemistry. 1985;24(10):2440–2446. doi: 10.1021/bi00331a008. [DOI] [PubMed] [Google Scholar]
  • 37.Kodati VR, Eljastimi R, Lafleur M. Contribution of the Intermolecular Coupling and Librotorsional Mobility in the Methylene Stretching Modes in the Infrared-Spectra of Acyl Chains. J. Phys. Chem. 1994;98(47):12191–12197. doi: 10.1021/j100098a012. [DOI] [Google Scholar]
  • 38.Skolova B, et al. Different phase behavior and packing of ceramides with long (C16) and very long (C24) acyls in model membranes: infrared spectroscopy using deuterated lipids. J. Phys. Chem. B. 2014;118(35):10460–70. doi: 10.1021/jp506407r. [DOI] [PubMed] [Google Scholar]
  • 39.Mendelsohn R, Flach CR, Moore DJ. Determination of molecular conformation and permeation in skin via IR spectroscopy, microscopy, and imaging. Biochim. Biophys. Acta. 2006;1758(7):923–33. doi: 10.1016/j.bbamem.2006.04.009. [DOI] [PubMed] [Google Scholar]
  • 40.Snyder RG, Schachtschneider JH. Vibrational analysis of the n-paraffins—I. Spectrochim. Acta. 1963;19(1):85–116. doi: 10.1016/0371-1951(63)80095-8. [DOI] [Google Scholar]
  • 41.Motta S, et al. Abnormality of water barrier function in psoriasis. Role of ceramide fractions. Arch. Dermatol. 1994;130(4):452–6. doi: 10.1001/archderm.1994.01690040056007. [DOI] [PubMed] [Google Scholar]
  • 42.De Paepe K, Houben E, Adam R, Wiesemann F, Rogiers V. Validation of the VapoMeter, a closed unventilated chamber system to assess transepidermal water loss vs. the open chamber Tewameter. Skin Res. Technol. 2005;11(1):61–9. doi: 10.1111/j.1600-0846.2005.00101.x. [DOI] [PubMed] [Google Scholar]
  • 43.Sochorova M, et al. Permeability Barrier and Microstructure of Skin Lipid Membrane Models of Impaired Glucosylceramide Processing. Sci. Rep. 2017;7(1):6470. doi: 10.1038/s41598-017-06990-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Netzlaff F, Kostka KH, Lehr CM, Schaefer UF. TEWL measurements as a routine method for evaluating the integrity of epidermis sheets in static Franz type diffusion cells in vitro. Limitations shown by transport data testing. Eur. J. Pharm. Biopharm. 2006;63(1):44–50. doi: 10.1016/j.ejpb.2005.10.009. [DOI] [PubMed] [Google Scholar]
  • 45.Chilcott RP, Dalton CH, Emmanuel AJ, Allen CE, Bradley ST. Transepidermal water loss does not correlate with skin barrier function in vitro. J. Invest. Dermatol. 2002;118(5):871–5. doi: 10.1046/j.1523-1747.2002.01760.x. [DOI] [PubMed] [Google Scholar]
  • 46.Pullmannova P, et al. Effects of sphingomyelin/ceramide ratio on the permeability and microstructure of model stratum corneum lipid membranes. Biochim. Biophys. Acta. 2014;1838(8):2115–26. doi: 10.1016/j.bbamem.2014.05.001. [DOI] [PubMed] [Google Scholar]
  • 47.Vavrova K, Hrabalek A, Mac-Mary S, Humbert P, Muret P. Ceramide analogue 14S24 selectively recovers perturbed human skin barrier. Br. J. Dermatol. 2007;157(4):704–12.. doi: 10.1111/j.1365-2133.2007.08113.x. [DOI] [PubMed] [Google Scholar]
  • 48.Di Nardo A, Wertz P, Giannetti A, Seidenari S. Ceramide and cholesterol composition of the skin of patients with atopic dermatitis. Acta Derm. Venereol. 1998;78(1):27–30. doi: 10.1080/00015559850135788. [DOI] [PubMed] [Google Scholar]
  • 49.Ishikawa J, et al. Changes in the ceramide profile of atopic dermatitis patients. J. Invest. Dermatol. 2010;130(10):2511–4. doi: 10.1038/jid.2010.161. [DOI] [PubMed] [Google Scholar]
  • 50.Mitragotri S. Modeling skin permeability to hydrophilic and hydrophobic solutes based on four permeation pathways. J. Control. Release. 2003;86(1):69–92. doi: 10.1016/S0168-3659(02)00321-8. [DOI] [PubMed] [Google Scholar]
  • 51.Mitragotri S, et al. Mathematical models of skin permeability: an overview. Int. J. Pharm. 2011;418(1):115–29. doi: 10.1016/j.ijpharm.2011.02.023. [DOI] [PubMed] [Google Scholar]
  • 52.Kopečná M, et al. Esters of terpene alcohols as highly potent, reversible, and low toxic skin penetration enhancers. Sci. Rep. 2019;9(1):1–12.. doi: 10.1038/s41598-019-51226-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Gutknecht J, Walter A. Histamine, theophylline and tryptamine transport through lipid bilayer membranes. Biochim. Biophys. Acta. 1981;649(2):149–54. doi: 10.1016/0005-2736(81)90401-6. [DOI] [PubMed] [Google Scholar]
  • 54.Halling-Overgaard AS, et al. Skin absorption through atopic dermatitis skin: a systematic review. Brit. J. Dermatol. 2017;177(1):84–106. doi: 10.1111/bjd.15065. [DOI] [PubMed] [Google Scholar]
  • 55.Sochorova M, et al. Permeability and microstructure of cholesterol-depleted skin lipid membranes and human stratum corneum. J. Colloid Interf. Sci. 2019;535:227–238. doi: 10.1016/j.jcis.2018.09.104. [DOI] [PubMed] [Google Scholar]
  • 56.Duan J, Merrill AH., Jr. 1-Deoxysphingolipids Encountered Exogenously and Made de Novo: Dangerous Mysteries inside an Enigma. J. Biol. Chem. 2015;290(25):15380–9. doi: 10.1074/jbc.R115.658823. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.McIntosh TJ, Waldbillig RC, Robertson JD. The molecular organization of asymmetric lipid bilayers and lipid-peptide complexes. Biochim. Biophys. Acta. 1977;466(2):209–30.. doi: 10.1016/0005-2736(77)90220-6. [DOI] [PubMed] [Google Scholar]
  • 58.Stahlberg S, et al. Probing the role of the ceramide acyl chain length and sphingosine unsaturation in model skin barrier lipid mixtures by (2)H solid-state NMR spectroscopy. Langmuir. 2015;31(17):4906–15. doi: 10.1021/acs.langmuir.5b00751. [DOI] [PubMed] [Google Scholar]
  • 59.Bouwstra JA, Honeywell-Nguyen PL, Gooris GS, Ponec M. Structure of the skin barrier and its modulation by vesicular formulations. Prog. Lipid Res. 2003;42(1):1–36. doi: 10.1016/S0163-7827(02)00028-0. [DOI] [PubMed] [Google Scholar]
  • 60.Groen D, et al. Disposition of ceramide in model lipid membranes determined by neutron diffraction. Biophys. J. 2011;100(6):1481–9. doi: 10.1016/j.bpj.2011.02.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Pham QD, Bjorklund S, Engblom J, Topgaard D, Sparr E. Chemical penetration enhancers in stratum corneum - Relation between molecular effects and barrier function. J. Control. Release. 2016;232:175–87. doi: 10.1016/j.jconrel.2016.04.030. [DOI] [PubMed] [Google Scholar]
  • 62.Lister MD, Ruan ZS, Bittman R. Interaction of Sphingomyelinase with Sphingomyelin Analogs Modified at the C-1 and C-3 Positions of the Sphingosine Backbone. Biochim. Biophys. Acta. 1995;1256(1):25–30. doi: 10.1016/0005-2760(94)00249-X. [DOI] [PubMed] [Google Scholar]
  • 63.Kan CC, Ruan ZS, Bittman R. Interaction of cholesterol with sphingomyelin in bilayer membranes: evidence that the hydroxy group of sphingomyelin does not modulate the rate of cholesterol exchange between vesicles. Biochemistry. 1991;30(31):7759–7766. doi: 10.1021/bi00245a013. [DOI] [PubMed] [Google Scholar]
  • 64.Gronberg L, Ruan ZS, Bittman R, Slotte JP. Interaction of cholesterol with synthetic sphingomyelin derivatives in mixed monolayers. Biochemistry. 1991;30(44):10746–54. doi: 10.1021/bi00108a020. [DOI] [PubMed] [Google Scholar]
  • 65.Ranck J, Zaccai G, Luzzati V. The structure of a lipid–water lamellar phase containing two types of lipid monolayers. An X-ray and neutron scattering study. Journal of Applied Crystallography. 1980;13(6):505–512. doi: 10.1107/S0021889880012678. [DOI] [Google Scholar]
  • 66.Kumar K, et al. The Lgamma Phase of Pulmonary Surfactant. Langmuir. 2018;34(22):6601–6611. doi: 10.1021/acs.langmuir.8b00460. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Ranck JL, et al. Order-disorder conformational transitions of the hydrocarbon chains of lipids. J. Mol. Biol. 1974;85(2):249–77.. doi: 10.1016/0022-2836(74)90363-5. [DOI] [PubMed] [Google Scholar]
  • 68.Funari SS, Rapp G, Richter F. Double-Bilayer: A New Phase Formed by Lysophospholipids and the Corresponding Fatty Acid. Quim. Nova. 2009;32(4):908–912. doi: 10.1590/S0100-40422009000400015. [DOI] [Google Scholar]
  • 69.Pascher I. Molecular Arrangements in Sphingolipids Conformation and Hydrogen-Bonding of Ceramide and Their Implication on Membrane Stability and Permeability. Biochim. Biophys. Acta. 1976;455(2):433–451. doi: 10.1016/0005-2736(76)90316-3. [DOI] [PubMed] [Google Scholar]
  • 70.Bollinger CR, Teichgraber V, Gulbins E. Ceramide-enriched membrane domains. Biochim. Biophys. Acta. 2005;1746(3):284–94. doi: 10.1016/j.bbamcr.2005.09.001. [DOI] [PubMed] [Google Scholar]
  • 71.Skolova B, et al. The role of the trans double bond in skin barrier sphingolipids: permeability and infrared spectroscopic study of model ceramide and dihydroceramide membranes. Langmuir. 2014;30(19):5527–35. doi: 10.1021/la500622f. [DOI] [PubMed] [Google Scholar]
  • 72.Schroeter A, et al. Phase separation in ceramide[NP] containing lipid model membranes: neutron diffraction and solid-state NMR. Soft Matter. 2017;13(10):2107–2119. doi: 10.1039/C6SM02356H. [DOI] [PubMed] [Google Scholar]
  • 73.Fasano WJ, Hinderliter PM. The Tinsley LCR Databridge Model 6401 and electrical impedance measurements to evaluate skin integrity in vitro. Toxicol. In Vitro. 2004;18(5):725–9. doi: 10.1016/j.tiv.2004.01.003. [DOI] [PubMed] [Google Scholar]
  • 74.Janůšová B, et al. Amino acid derivatives as transdermal permeation enhancers. J. Control. Release. 2013;165(2):91–100. doi: 10.1016/j.jconrel.2012.11.003. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary info. (10.6MB, docx)

Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES